Blog
Psilocybin trial at UMC Utrecht
UMC Utrecht in the Netherlands has started recruitment for the Compass Pathways-sponsored phase 3 trial of psilocybin-assisted therapy (PAT) for treatment-resistant depression (TRD). This will be the second phase 3 trial initiated by the biotech company, which recently announced positive results from its initial multi-center trial of PAT for TRD. Besides UMC Utrecht, recruitment is also taking place at the UMCG (Groningen) and the Leiden University Medical Center.Adults suffering from major...
Ethnoracial inclusion in clinical trials of psychedelics
Despite increasing awareness of the need for diversity in clinical research, psychedelic studies have shown limited ethnoracial representation. A systematic review of 39 studies on psychedelic treatments for psychiatric or substance use disorders, published between January 1, 1994, and May 24, 2024, highlights this ongoing issue. The review, including 16 studies (n = 282) from a 2018 review and 23 new studies (n = 1111), revealed that participants in studies published after 2017 were...
Participate: The role of memories in psychedelic experience
Are you planning to take a psychedelic in the next few weeks in any context? Please join the AutoPsy study to help us better understand the role of memories in psychedelic experiences! For more...
MAPS announces submission of New Drug Application to the FDA for MDMA-assisted therapy for PTSD
MAPS Public Benefit Corporation (MAPS PBC) has reached a significant milestone by submitting a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for MDMA (midomafetamine...
Pharmahuasca passes its first clinical test
This study by Dornbierer et al. (2023) explores alternative administration methods for ayahuasca's principle psychoactive components, specifically DMT and harmine. It appears to show promising...
Participate: The role of memories in psychedelic experience
Are you planning to take a psychedelic in the next few weeks in any context? Please join the AutoPsy study to help us better understand the role of memories in psychedelic experiences! For more...
MAPS announces submission of New Drug Application to the FDA for MDMA-assisted therapy for PTSD
MAPS Public Benefit Corporation (MAPS PBC) has reached a significant milestone by submitting a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for MDMA (midomafetamine...
Pharmahuasca passes its first clinical test
This study by Dornbierer et al. (2023) explores alternative administration methods for ayahuasca's principle psychoactive components, specifically DMT and harmine. It appears to show promising...
Trait mindfulness and personality characteristics in a microdosing ADHD sample
This study explores the effects of microdosing psychedelics on mindfulness and personality traits in adults diagnosed with attention deficit hyperactivity disorder (ADHD) or experiencing severe ADHD...
Trait mindfulness and personality characteristics in a microdosing ADHD sample
This study explores the effects of microdosing psychedelics on mindfulness and personality traits in adults diagnosed with attention deficit hyperactivity disorder (ADHD) or experiencing severe ADHD...
Extended difficulties following the use of psychedelic drugs
A recently published study by Evans et al. (2023) has investigated long-term psychological distress following the use of psychedelic drugs. Long-term adverse experiences following psychedelic use...
First clinical trial results on psilocybin for anorexia nervosa
Earlier this week, the first-ever clinical trial results of a study investigating the effects of psilocybin on females with anorexia nervosa (AN) were published in Nature Medicine. It concerns a...
LSD couples study at Maastricht University
The University of Maastricht has started a study regarding the effects of LSD (lysergic acid diethylamide) on brain activity and social behavior. For this study, they are looking for healthy...
Watch now: Dr. Daan Oostveen – Psychedelic Humanities
Watch the recording of our lecture by Dr. Daan Oostveen on psychedelic humanities. The video is now available on the APRA YouTube channel. Be sure to check out our previous videos and subscribe to...
Apply now for a psilocybin neuroimaging study in Amsterdam!
A study by APRA founder Marco Aqil at the Spinoza Center for Neuroimaging is investigating the effects of psilocybin on visual processing with a 7-Tesla fMRI scanner. This is the first-ever...
Do you self-experiment with psychedelics? Participate in this study
Self-experimentation with psychedelics is a contentious topic. The PRSM lab at Leiden University is conducting a study on self-experimentation with psychedelics among psychedelic researchers,...
The Market of Non-Hallucinogenic Psychedelics
Patentable molecules for the sober mind. In recent years, psychedelic science has regained relevance in the field of psychiatric treatments with a radical idea. Research is showing that altered...
Dangers for the Psychedelic Renaissance
Opinion piece A recent viewpoint paper from the Griffiths Lab delivers a cautionary note on some trends which, according to the authors, might jeopardise the ongoing development of the...
Considerations on Esketamine for Depression
Research, potential, and limitations Back in 1956, ketamine was originally derived from phencyclidine as a shorter acting analogue with less delirious side effects. Li, L., & Vlisides, P....
Extended difficulties following the use of psychedelic drugs
A recently published study by Evans et al. (2023) has investigated long-term psychological distress following the use of psychedelic drugs. Long-term adverse experiences following psychedelic use...
First clinical trial results on psilocybin for anorexia nervosa
Earlier this week, the first-ever clinical trial results of a study investigating the effects of psilocybin on females with anorexia nervosa (AN) were published in Nature Medicine. It concerns a...
LSD couples study at Maastricht University
The University of Maastricht has started a study regarding the effects of LSD (lysergic acid diethylamide) on brain activity and social behavior. For this study, they are looking for healthy...
Watch now: Dr. Daan Oostveen – Psychedelic Humanities
Watch the recording of our lecture by Dr. Daan Oostveen on psychedelic humanities. The video is now available on the APRA YouTube channel. Be sure to check out our previous videos and subscribe to...
Apply now for a psilocybin neuroimaging study in Amsterdam!
A study by APRA founder Marco Aqil at the Spinoza Center for Neuroimaging is investigating the effects of psilocybin on visual processing with a 7-Tesla fMRI scanner. This is the first-ever...
Do you self-experiment with psychedelics? Participate in this study
Self-experimentation with psychedelics is a contentious topic. The PRSM lab at Leiden University is conducting a study on self-experimentation with psychedelics among psychedelic researchers,...
The Market of Non-Hallucinogenic Psychedelics
Patentable molecules for the sober mind. In recent years, psychedelic science has regained relevance in the field of psychiatric treatments with a radical idea. Research is showing that altered...
Dangers for the Psychedelic Renaissance
Opinion piece A recent viewpoint paper from the Griffiths Lab delivers a cautionary note on some trends which, according to the authors, might jeopardise the ongoing development of the...
Considerations on Esketamine for Depression
Research, potential, and limitations Back in 1956, ketamine was originally derived from phencyclidine as a shorter acting analogue with less delirious side effects. Li, L., & Vlisides, P....
Discussing Tolerance with Dr. Tobias Buchborn
Tobias Buchborn (PhD) studied Psychology at the OvG University, Magdeburg Germany, and within his Diploma thesis investigated the antidepressant-like properties of repeated LSD administration in an...